94 related articles for article (PubMed ID: 4473986)
1. Structure activity relationships in a series of anti-neoplastic dinitrophenyl aziridines--protein binding studies.
Hickman JA
Biochem Pharmacol; 1974 Oct; 23(20):2833-8. PubMed ID: 4473986
[No Abstract] [Full Text] [Related]
2. The metabolism of the anti-tumour agent 1(1-aziridinyl)- 2,4-dinitrobenzene (CB 1837).
Connors TA; Hickman JA; Jarman M; Melzack DH; Ross WC
Biochem Pharmacol; 1975 Sep; 24(18):1665-70. PubMed ID: 1191326
[No Abstract] [Full Text] [Related]
3. [Metabolism of the antineoplastic agent N-pyrimidly-2N1, N2-di-(ethylene)-triamide phosphate (fosfemid)].
Safonova TS; Linberg LF; Presnova ZhF; Kuriatov NS; Chernov VA
Dokl Akad Nauk SSSR; 1974; 219(5):1271-2. PubMed ID: 4442341
[No Abstract] [Full Text] [Related]
4. Effects of ascorbic acid on biologically obtained diaziquone free radicals.
Gutierrez PL; Egorin MJ; Davis TA; Bachur NR
Biochem Pharmacol; 1985 Jul; 34(13):2394-7. PubMed ID: 2990485
[No Abstract] [Full Text] [Related]
5. Cytotoxic activity and fragmentation of aziridines in microsomes.
Hata Y; Watanabe M; Shiratori O; Takase S
Biochem Biophys Res Commun; 1978 Feb; 80(4):911-6. PubMed ID: 637875
[No Abstract] [Full Text] [Related]
6. Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma and cerebrospinal fluid kinetics.
Bachur NR; Collins JM; Kelley JA; Van Echo DA; Kaplan RS; Whitacre M
Clin Pharmacol Ther; 1982 May; 31(5):650-5. PubMed ID: 7075113
[TBL] [Abstract][Full Text] [Related]
7. [Study of the pharmacokinetics of phosphemide in rats with the use of physico-chemical methods].
Safonova TS; Presnova ZhF; Linberg LF; Chernov VA; Kuriatov NS
Farmakol Toksikol; 1975; 38(4):491-4. PubMed ID: 1213145
[TBL] [Abstract][Full Text] [Related]
8. Covalent binding studies on the 14C-labeled antitumor compound 2,5-bis(1-aziridinyl)-1,4-benzoquinone. Involvement of semiquinone radical in binding to DNA, and binding to proteins and bacterial macromolecules in situ.
Lusthof KJ; De Mol NJ; Janssen LH; Egberink RJ; Verboom W; Reinhoudt DN
Chem Biol Interact; 1990; 76(2):193-209. PubMed ID: 1699678
[TBL] [Abstract][Full Text] [Related]
9. The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2).
Knox RJ; Boland MP; Friedlos F; Coles B; Southan C; Roberts JJ
Biochem Pharmacol; 1988 Dec; 37(24):4671-7. PubMed ID: 3144286
[TBL] [Abstract][Full Text] [Related]
10. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of diaziquone after three different dosage regimens.
Bjornsson TD; Schold SC; Friedman HS; Schneider D; Falletta JM
Cancer Treat Rep; 1985 Dec; 69(12):1383-5. PubMed ID: 4075314
[TBL] [Abstract][Full Text] [Related]
12. The metabolism of the anti-tumour agent 5-(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).
Jarman M; Melzack DH; Ross WC
Biochem Pharmacol; 1976 Nov; 25(22):2475-8. PubMed ID: 985569
[No Abstract] [Full Text] [Related]
13. Enzyme-induced aziridine formation by rat liver microsomes.
Hata Y; Watanabe M
Biochem Biophys Res Commun; 1983 Jan; 110(1):220-7. PubMed ID: 6838512
[TBL] [Abstract][Full Text] [Related]
14. A new metabolic reaction of diaziridines by rat liver microsomes.
Hata Y; Watanabe M
Biochem Biophys Res Commun; 1982 May; 106(2):526-32. PubMed ID: 7104007
[No Abstract] [Full Text] [Related]
15. Fragmentation reaction of ylide. 5. A new metabolic reaction of aziridine derivatives.
Hata Y; Watanabe M; Matsubara T; Touchi A
J Am Chem Soc; 1976 Sep; 98(19):6033-6. PubMed ID: 965638
[No Abstract] [Full Text] [Related]
16. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
[TBL] [Abstract][Full Text] [Related]
17. Determination of diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone in plasma by solid-phase extraction and high-performance liquid chromatography.
Betteridge RF; Bosanquet AG; Hunt P; Gilby ED
J Chromatogr; 1988 Nov; 432():352-7. PubMed ID: 3220904
[No Abstract] [Full Text] [Related]
18. Molecular orbital calculations on tumour-inhibitory phenyl aziridines: QSARs.
Lewis DF
Xenobiotica; 1989 Mar; 19(3):341-56. PubMed ID: 2750200
[TBL] [Abstract][Full Text] [Related]
19. [Kinetics of accumulation and elimination of 14C-dipine, an antineoplastic drug].
Korolev GK; Kurasova VG; Kurchatova VV
Farmakol Toksikol; 1978; 41(4):473-80. PubMed ID: 668875
[TBL] [Abstract][Full Text] [Related]
20. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.
Lalka D; Jusko WJ; Bardos TJ
J Pharm Sci; 1975 Feb; 64(2):230-5. PubMed ID: 236372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
